Success Metrics

Clinical Success Rate

90.0%

Based on 9 completed trials

Completion Rate

90%(9/10)

Active Trials

1(5%)

Results Posted

0%(0 trials)

Terminated

1(5%)

Phase Distribution

Ph not_applicable

71%

Ph phase_3

10%

Ph early_phase_1

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution18 total trials

Early Phase 1First-in-human

1(5.6%)

Phase 3Large-scale testing

2(11.1%)

N/ANon-phased studies

15(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

9 of 12 finished

Non-Completion Rate

25.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(6)

Completed(9)

Terminated(3)

Other(3)

Detailed Status

Completed9

Not yet recruiting5

unknown3

Withdrawn2

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

90.0%

Most Advanced

Phase 3

Trials by Phase

Early Phase 11 (5.6%)

Phase 32 (11.1%)

N/A15 (83.3%)

Trials by Status

withdrawn210%

not_yet_recruiting524%

recruiting15%

completed943%

terminated15%

unknown314%

Recent Activity

1 active trials

Showing 5 of 21

recruitingnot_applicable

Intermittent Oro-esophageal Tube Feeding on Cerebral Small Vessel Disease Patients With Dysphagia

NCT06179550

View all 21 trials

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more

NCT06347120Not Applicable

Place of Nasogastric Tube in Uncomplicated Adhesive Small Bowel Obstruction

Recruiting

NCT06328829Not Applicable

Intermittent Oral Tube in Alzheimer's Patients

Not Yet Recruiting

NCT06328881Not Applicable

Effect of Intermittent Oral Tube on Dysphagia in Parkinson's Disease Patients

Not Yet Recruiting

NCT06303947Not Applicable

Effect of Oral Enteral Nutrition Feeding in Parkinson Disease

Not Yet Recruiting

NCT06179550Not Applicable

Intermittent Oro-esophageal Tube Feeding on Cerebral Small Vessel Disease Patients With Dysphagia

Terminated

NCT06303999Not Applicable

Effect of Oral Enteral Nutrition on Cerebral Small Vessel Disease

Completed

NCT06301607Not Applicable

The Impact of Oral and Nasal Enteral Nutrition Feeding Quantity in Stroke Patients

Not Yet Recruiting

NCT06301750Not Applicable

Oral Enteral Nutrition Feeding in Alzheimer's Patients

Not Yet Recruiting

NCT06206122Not Applicable

Effect of Intermittent Oro-esophageal Tube Feeding on Dysphagic Patients With Parkinson Disease

Withdrawn

NCT06220292Not Applicable

Intermittent Oral-esophageal Tube Feeding in Alzheimer's Patients With Dysphagia

Withdrawn

NCT05517707

Gravitas Feeding Tube System Placement in Neonates

Completed

NCT05729971

Nasogastric Tube After Laparoscopic Heller-Dor Myotomy

Completed

NCT04615702

Evidence Based Management of Acute Biliary Pancreatitis

Completed

NCT02594956Not Applicable

Impact of the Absence of Nasogastric Decompression After Pancreaticoduodenectomy

Completed

NCT02823249Not Applicable

Effect of Amino Acids and Sugar Alcohols on Satiation Peptides and Activation of Specific Brain Regions

Completed

NCT01139853Early Phase 1

Post-Operative Impact of Nasogastric Tubes on Rates of Emesis in Infants Diagnosed With Pyloric Stenosis

Completed

NCT01991392Not Applicable

Is Nasogastric Tube Necessary After Pancreaticoduodenectomy?

Unknown

NCT01966406Not Applicable

Is Nasogastric Tube Necessary After Pancreaticoduodenectomy?

Unknown

NCT00798824Not Applicable

The Impact of Nasogastric Indwelling Versus Oral Intermittent Tube Feeding Methods on Premature Infants

Completed

NCT00738478Phase 3

Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients

Completed

Drug Details

Intervention Type: DEVICE
Total Trials: 21